The role of disulfide bonds in the structure and function of murine epidermal growth factor (mEGF)

References

• Alroy, I Yarden, Y 1997. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410:83–86.
   Google Scholar
• Araki, F Nakamura, H Nojima, N Tsukumo, K Sakamoto, S 1989. Stability of recombinant human epidermal growth factor in various solutions. Chem Pharm Bull (Tokyo) 37:404–406.
   Google Scholar
• Ball HL King DS, Cohen FE, Prusiner SB, Baldwin MA. 2001. Engineering the prion protein using chemical synthesis. J Peptide Res 58:357.
   Google Scholar
• Barnham KJ Torres AM, Alewood, D Alewood PF, Domagala, T Nice EC, Norton RS. 1998. Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor. Protein Sci 7:1738–1749.
   Google Scholar
• Bax, A Davis DG. 1985. MILEV-17 based two dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 65:355–360.
   Google Scholar
• Bewley TA Brovetto-Cruz, J Li CH. 1969. Human pituitary growth hormone. Physicochemical investigations of the native and reduced-alkylated protein. Biochemistry 8:4701–4708.
   Google Scholar
• Brems DN Brown PL, Becker GW. 1990. Equilibrium denaturation of human growth hormone and its cysteine-modified forms. J Biol Chem 265:5504–5511.
   Google Scholar
• Burgess AW Sizeland AM. 1990. Growth factors and the gut. J Gastroenterol Hepatol 5(Suppl. 1):10–21.
   Google Scholar
• Burgess AW Knesel, J Sparrow LG, Nicola NA, Nice EC. 1982. Two forms of murine epidermal growth factor: Rapid separation by using reverse-phase high performance liquid chromatog-raphy. Proc Natl Acad Sci USA 79:5753–5757.
   Google Scholar
• Burgess AW Lloyd CJ, Nice EC. 1983. Murine epidermal growth factor: Heterogeneity on high resolution ion-exchange chroma-tography. EMBO J 2:2065–2069.
   Google Scholar
• Burgess AW Lloyd CJ, Smith, S Stanley, E Walker, F Fabri, L Simpson RJ, Nice EC. 1988. Murine epidermal growth factor: Structure and function. Biochemistry 27:4977–4985.
   Google Scholar
• Burgess AW Cho HS, Eigenbrot, C Ferguson KM, Garrett TP, Leahy DJ, Lemmon MA, Sliwkowski MX, Ward CW, Yokoyama, S 2003. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 12:541–552.
   Google Scholar
• Campbell ID Cooke RM, Baron, M Harvey TS, Tappin MJ. 1989. The solution structures of epidermal growth factor and transforming growth factor alpha. Prog Growth Factor Res 1:13–22.
   Google Scholar
• Carver JA Cooke RM, Esposito, G Campbell, D Gregory, H Sheard, B 1986. A high resolution 1H NMR study of the solution structure of human epidermal growth factor. FEBS Lett 205:77–81.
   Google Scholar
• Chang JY Schindler, P Ramseier, U Lai PH. 1995. The disulfide folding pathway ofhuman epidermal growth factor. J Biol Chem 270:9207–9216.
   Google Scholar
• Chang JY Li, L Lai PH. 2001. A major kinetic trap for the oxidative folding of human epidermal growth factor. J Biol Chem 276:4845–4852.
   Google Scholar
• Cho HS Leahy DJ. 2002. Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297:1330–1333.
   Google Scholar
• Cho HS Mason, K Ramyar KX, Stanley AM, Gabelli SB, Denney DW, Jr, Leahy DJ. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:756–760.
   Google Scholar
• Cooke RM Wilkinson AJ, Baron, M et al. 1987. The solution structure of human epidermal growth factor. Nature 327:339–341.
   Google Scholar
• Defeo-Jones, D Tai JY, Wegrzyn RJ, Vuocolo GA, Baker AE, Payne LS, Garsky VM, Oliff, A Riemen MW. 1988. Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha. Mol Cell Biol 8:2999–3007.
   Google Scholar
• Domagala, T Konstantopoulos, N Smyth, F Jorissen RN, Fabri, L Geleick, D Lax, I Schlessinger, J Sawyer, W Howlett GJ, Burgess AW, Nice EC. 2000. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor. Growth Factors 18:11–29.
   Google Scholar
• Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77.
   Google Scholar
• Ferguson KM Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11:507–517.
   Google Scholar
• Ferrer, M Woodward, C Barany, G 1992. Solid-phase synthesis of bovine pancreatic trypsin inhibitor (BPTI) and two analogues. A chemical approach for evaluating the role of disulfide bridges in protein folding and stability. Int J Pept Protein Res 40:94–207.
   Google Scholar
• Ferrer, M Barany, G Woodward, C 1995. Partially folded, molten globule and molten coil states of bovine pancreatic trypsin inhibitor. Nat Struct Biol 2:211–217.
   Google Scholar
• Garrett TPJ McKern NM, Lou, M Elleman TC, Adams TE, Lovrecz GO, Zhu H-J, Walker, F Hoyne PA, Jorissen RN, Nice EC, Burgess AW, Ward CW. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor-a. Cell 110:763–773.
   Google Scholar
• Garrett TPJ McKern NM, Lou, M Elleman TC, Adams TE, Lovrecz GO, Kofler, M Jorissen RN, Nice EC, Burgess AW, Ward CW. 2003. The first 3 domains of ErbB2 ectodomain adopt a pseudo-active form of the receptor. Mol Cell 11:495–505.
   Google Scholar
• Gregory, H Thomas CE, Young JA, Willshire IR, Garner, A 1988. The contribution of the C-terminal undecapeptide sequence of urogastron-epidermal growth factor to its biological action. Regul Peptides 22:217–226.
   Google Scholar
• Groenen LC Nice EC, Burgess AW. 1994. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11:235–257.
   Google Scholar
• Han KH Ferretti JA, Niu CH, Lokeshwar, V Clarke, R Katz, D 1988. Conformational and receptor binding properties of human EGF and TGF-alpha second loop fragments. J Mol Recognit 1:116–123.
   Google Scholar
• Heath WF Merrifield RB. 1986. A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule. Proc Natl Acad Sci USA 83:6367–6371.
   Google Scholar
• Holladay LA Savage CR, Jr, Cohen, S Puett, D 1976. Conformation and unfolding thermodynamics of epidermal growth factor and derivatives. Biochemistry 15:2624–2633.
   Google Scholar
• Husbyn, M Orning, L Sakariassen KS, Fischer PM. 1997. Peptides corresponding to the second epidermal growth factor-like domain of human blood coagulation factor VII: Synthesis, folding and biological activity. J Pept Res 50:475–482.
   Google Scholar
• Hynes NE Stern DF. 1994. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198:165–184.
   Google Scholar
• Jacobsen NE Abadi, N Sliwkowski MX, Reilly, D Skelton NJ, Fairbrother WJ. 1996. High-resolution solution structure of the EGF-like domain of heregulin-alpha. Biochemistry 35: 3402–3417.
   Google Scholar
• Jenner, J Meier BH, Bachmann, P Ernst RR. 1979. Investigation of chemical exchange processes by two dimensional NMR spectroscopy. J Chem Phys 71:4546–4553.
   Google Scholar
• Karim CB Paterlini MG, Reddy LG, Hunter GW, Barany DD, Thomas DD. 2001. Role of cysteine residues in structural stability and function of a transmembrane helix bundle. J Biol Chem 276:38814–38819.
   Google Scholar
• Komoriya, A Hortsch, M Meyers, C Smith, M Kanety, H Schlessinger, J 1984. Biologically active synthetic fragments of epidermal growth factor: Localization of a major receptor-binding region. Proc Natl Acad Sci USA 81:1351–1355.
   Google Scholar
• Kumar, A Ernst RR, Wuthrich, K 1980. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton -proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun 95:1–6.
   Google Scholar
• Lazar, E Vicenzi, E Van Obberghen-Schilling, E Wolff, B Dalton, S Watanabe, S Sporn MB. 1989. Transforming growth factor alpha: An aromatic side chain at position 38 is essential for biological activity. Mol Cell Biol 9:860–864.
   Google Scholar
• Lemmon MA Bu, Z Ladbury JE, Zhou, M Pinchasi, D Lax, I Engelman DM, Schlessinger, J 1997. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J 16:281–294.
   Google Scholar
• Louie GV Yang, W Bowman ME, Choe, S 1997. Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor. Mol Cell 1:67–78.
   Google Scholar
• Lu HS Chai JJ, Li, M Huang BR, He CH, Bi RC. 2001. Crystal structure of human epidermal growth factor and its dimeriza-tion. J Biol Chem 276:34913–34917.
   Google Scholar
• Matsuzaki, K Nakayama, M Fukui, M Otaka, A Funakoshi, S Fujii, N Bessho, K Miyajima, K 1993. Role of disulfide linkages in tachyplesin-lipid interactions. Biochemistry 32:11704–11710.
   Google Scholar
• McInnes, C Hoyt DW, Harkins RN, Pagila RN, Debanne MT, O'Connor-McCourt, M Sykes BD. 1996. NMR study of the transforming growth factor-alpha (TGF-alpha)-epidermal growth factor receptor complex. Visualization of human TGF-alpha binding determinants through nuclear Overhauser enhancement analysis. J Biol Chem 271:32204–32211.
   Google Scholar
• McInnes, C Wang, J Al Moustafa AE, Yansouni, C O'Connor-McCourt, M Sykes BD. 1998. Minimization of transforming growth factor-alpha (TGF-alpha) through NMR analysis of the receptor-bound ligand. Design, solution structure, and activity of TGF-alpha 8-50. J Biol Chem 273:27357–27363.
   Google Scholar
• McInnes, C Grothe, S O'Connor-McCourt, M Sykes BD. 2000. NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor. Protein Eng 13:143–147.
   Google Scholar
• Miura, K Doura, H Aizawa, T Tada, H Seno, M Yamada, H Kawano, K 2002. Solution structure of betacellulin, a new member of EGF-family ligands. Biochem Biophys Res Commun 294:1040–1046.
   Google Scholar
• Montelione GT Wuthrich, K Nice EC, Burgess AW, Scheraga HA. 1986. Indentification of two anti-parallel p-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance. Proc Natl Acad Sci USA 83:8594–8598.
   Google Scholar
• Montelione GT Wuthrich, K Nice EC, Burgess AW, Scheraga HA. 1987. Solution structure of murine epidermal growth factor: Determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry. Proc Natl Acad Sci USA 84:5226–5230.
   Google Scholar
• Montelione GT Wuthrich, K Burgess AW, Nice EC, Wagner, G Gibson KD, Scheraga HA. 1992. Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. Biochemistry 31:236–249.
   Google Scholar
• Nagata, K Kohda, D Hatanaka, H Ichikawa, S Matsuda, S Yamamoto, T Suzuki, A Inagaki, F 1994. Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4. EMBO J 13:3517–3523.
   Google Scholar
• Narhi LO Arakawa, T McGinley MD, Rohde MF, Westcott KR. 1992. Circular dichroism of reduced and oxidized recombinant human epidermal growth factor. Int J Pept Protein Res 39: 182–187.
   Google Scholar
• Nice EC. 1990. Micropreparative LC of proteins. Nature 348:462–463.
   Google Scholar
• Nice EC. 1996. Micropreparative HPLC of proteins and peptides: Principles and applications. Biopolymers (Peptide Science) 40:319–341.
   Google Scholar
• Nice EC Domagala, T Fabri, L Nerrie, M Walker, F Jorissen RN, Burgess AW, Cui D-F, Zhang YS. 2002. Rapid microscale enzymic semisynthesis of epidermal growth factor (EGF) analogues. Growth Factors 20:71–80.
   Google Scholar
• Normanno, N Bianco, C De Luca, A Salomon DS. 2001. The role of EGF-related peptides in tumor growth. Front Biosci 6:D685-D707.
   Google Scholar
• Normanno, N Bianco, C De Luca, A Maiello MR, Salomon DS. 2003. Target-based agents against ErbB receptors and their ligands: A novel approach to cancer treatment. Endocr Relat Cancer 10:1–21.
   Google Scholar
• Odaka, M Kohda, D Lax, I Schlessinger, J Inagaki, F 1997. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor. J Biochem (Tokyo) 122:116–121.
   Google Scholar
• Ogiso, H Ishitani, R Nureki, O Fukai, S Yamanaka, M Kim JH, Saito, K Sakamoto, A Inoue, M Shirouzu, M Yokoyama, S 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775–787.
   Google Scholar
• Ozawa, F Friess, H Tempia-Caliera, A KleeffJ, BuchlerMW. 2001. Growth factors and their receptors in pancreatic cancer. Teratog Carcinog Mutagenet 21:27–44.
   Google Scholar
• Piotto, M Saudek, V Sklenar, V 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR 2:661–665.
   Google Scholar
• van de Poll ML, van Vugt MJ, Lenferink AE, van Zoelen EJ. 1997. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity. Biochemistry 36:7425–7431.
   Google Scholar
• van de Poll ML, van Vugt MJ, Lenferink AE, van Zoelen EJ. 1998. Identification of the minimal requirements for binding to the human epidermal growth factor (EGF) receptor using chimeras of human EGF and an EGF repeat of Drosophila Notch. J Biol Chem 273:16075–16081.
   Google Scholar
• Prigent SA Lemoine NR. 1992. The type 1 (EGFR-related) family ofgrowth factor receptors and their ligands. Prog Growth Factor Res 4:1–24.
   Google Scholar
• Qi CF Liscia DS, Normanno, N Merlo, G Johnson GR, Gullick WJ, Ciardiello, F Saeki, T Brandt, R Kim, N et al. 1994. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Br J Cancer 69:903–910.
   Google Scholar
• Riese 2nd, DJ, Stern DF. 1998. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20:41–48.
   Google Scholar
• Rock FL Li, X Chong, P Ida, N Klein, M 1994. Roles of disulfide bonds in recombinant human interleukin 6 conformation. Biochemistry :5146–5154.
   Google Scholar
• Saeki, T Stromberg, K Qi CF, Gullick WJ, Tahara, E Normanno, N Ciardiello, F Kenney, N Johnson GR, Salomon DS. 1992. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res. 52:3467–3473.
   Google Scholar
• Sato, K Nakamura, T Mizuguchi, M Miura, K Tada, M Aizawa, T Gomi, T Miyamoto, K Kawano, K 2003. Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity. FEBS Lett 53:232–238.
   Google Scholar
• Scanlon DB Eefting, M Lloyd CJ, Burgess AW, Simpson RJ. 1987. Synthesis of biologically-active human transforming growth factor-alpha by fluorenylmethoxycarbonyl solid phase peptide chemistry. J Chem Soc: Chem Commun 25:516–518.
   Google Scholar
• Schlessinger, J 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211–225.
   Google Scholar
• Schlessinger, J 2002. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110:669–672.
   Google Scholar
• Schnolzer, M Alewood, P Jones, A Alewood, D Kent SB. 1992. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res 40:180–193.
   Google Scholar
• Shin SY Shimizu, M Ohtaki, T Munekata, E 1995. Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF). Peptides 16:205–210.
   Google Scholar
• Simpson RJ Smith JA, Moritz RL, O'Hare MJ, Rudland PS, Morrison JR, Lloyd CJ, Grego, B Burgess AW, Nice EC. 1985. Rat epidermal growth factor. Complete amino acid sequence: Homology with the corresponding murine and human proteins but truncated at both ends. Eur J Biochem 153:629–637.
   Google Scholar
• Spetzler JC Rao, C Tam JP. 1994. A novel strategy for the synthesis of the cysteine-rich protective antigen of the malaria merozoite surface protein (MSP-1). Knowledge-based strategy for disulfide formation. Int J Pept Protein Res 43:351–358.
   Google Scholar
• Tam JP. 1987. Synthesis of biologically active transforming growth factor alpha. Int J Pept Protein Res 29:421–431.
   Google Scholar
• Tam JP Marquardt, H Rosberger DF, Wong TW, Todaro GJ. 1984. Synthesis of biologically active rat transforming growth factor, I Nature 309:376–378.
   Google Scholar
• Tam JP Sheikh MA, Solomon DS, Ossowski, L 1986. Efficient synthesis of human type alpha transforming growth factor: Its physical and biological characterization. Proc Natl Acad Sci USA 83:8082–8086.
   Google Scholar
• Tam JP Wu C-R, Liu, W Zhang J-W. 1991. Disulfide bond formation in peptides by dimethylsulphoxide. Scope and aapplication. J Am Chem Soc 86:4099–4103.
   Google Scholar
• Walker, F Orchard SG, Jorissen RN, Hall NE, Zhang HH, Hoyne PA, Adams TE, Johns TG, Ward, C Garrett TP, Zhu HJ, Nerrie, M Scott AM, Nice EC, Burgess AW. 2004. Mar 11 (Epub ahead of print) CR1/CR2 interactions modulate the functions of the cell-surface epidermal growth factor receptor. J Biol Chem.
   Google Scholar
• Winter, J Lilie, H Rudolph, R 2002. Renaturation of human proinsulin—a study on refolding and conversion to insulin. Anal Biochem 310:148–155.
   Google Scholar
• Wishart DS Sykes BD, Richards FM. 1991. Simple techniques for the quantification of protein secondary structure by 1H NMR spectroscopy. FEBS Lett 293:72–80.
   Google Scholar
• Woo DD Clark-Lewis, I Chait BT, Kent SB. 1989. Chemical synthesis in protein engineering: Total synthesis, purification and covalent structural characterization of a mitogenic protein, human transforming growth factor-alpha. Protein Eng 3:29–37.
   Google Scholar
• Wuthrich, K 1983. Sequential individual resonance assignments in the 1H-NMR spectra ofpolypeptides and proteins. Biopolymers 22:131–138.
   Google Scholar
• Yarden, Y Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137.
   Google Scholar
• Youngman KM Spencer DB, Brems DN, DeFelippis MR. 1995. Kinetic analysis of the folding of human growth hormone. Influence of disulfide bonds. J Biol Chem 270:19816–19822.
   Google Scholar
• van Zoelen EJ, Stortelers, C Lenferink AE, Van de Poll ML. 2000. The EGF domain: Requirements for binding to receptors of the ErbB family. Vitam Horm 59:99–131.
   Google Scholar